Ruane, Cunniff & Goldfarb letter to shareholder for the third quarter 2015 discussing their long position in Valeant Pharmaceuticals.
Get The Full Series in PDF
Get the entire 10-part series on... Read More
An Ageing Population could help solve a problem where $1 trillion spent by Obama accomplished little.
Healthcare is a growing industry but rising budgetary pressures will constricting growth going forward... Read More
Bear markets beget portfolio losses, unhappy clients and, sadly, lawsuits against advisors. If you relied on any of the popular risk tolerance products to construct that portfolio, here’s how... Read More
UK hedge fund Polygon is upset at the negative performance of its most high profile holding: Quindell PLC (LON:QPP) (OTCMKTS:QUPPF). According to a recent investor letter reviewed by ValueWalk, Polygon... Read More
Are Low Volatility Stocks Bond Proxies?
The interest rate-sensitivity of the Low Volatility factor has increased in recent years
Mainly due to the sectoral biases from the long portfolio
... Read More
Ruth Porat, Chief Financial Officer at Morgan Stanley (NYSE:MS), spoke with Bloomberg Television's Stephanie Ruhle and Erik Schatzker today at the Milken Institute 2014 Global Conference. Porat discussed the... Read More